| Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages E Wauters, P Van Mol, AD Garg, S Jansen, Y Van Herck, L Vanderbeke, ... Cell research 31 (3), 272-290, 2021 | 315 | 2021 |
| Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L Vanderbeke, P Van Mol, Y Van Herck, F De Smet, S Humblet-Baron, ... Nature communications 12 (1), 4117, 2021 | 240 | 2021 |
| Capmatinib for the treatment of non-small cell lung cancer JF Vansteenkiste, C Van de Kerkhove, E Wauters, P Van Mol Expert review of anticancer therapy 19 (8), 659-671, 2019 | 94 | 2019 |
| Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the host V Lloréns-Rico, AC Gregory, J Van Weyenbergh, S Jansen, T Van Buyten, ... Nature communications 12 (1), 6243, 2021 | 71 | 2021 |
| Increased IL‐10‐producing regulatory T cells are characteristic of severe cases of COVID‐19 J Neumann, T Prezzemolo, L Vanderbeke, CP Roca, M Gerbaux, ... Clinical & translational immunology 9 (11), e1204, 2020 | 67 | 2020 |
| Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches F Cortiula, B Reymen, S Peters, P Van Mol, E Wauters, J Vansteenkiste, ... Annals of Oncology 33 (9), 893-908, 2022 | 62 | 2022 |
| Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019 M Metzemaekers, S Cambier, M Blanter, J Vandooren, AC de Carvalho, ... Clinical & Translational Immunology 10 (4), e1271, 2021 | 51 | 2021 |
| Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates B Malengier-Devlies, J Filtjens, K Ahmadzadeh, B Boeckx, ... Frontiers in Immunology 13, 861251, 2022 | 36 | 2022 |
| Single-cell transcriptomics identifies pathogenic T-helper 17.1 cells and pro-inflammatory monocytes in immune checkpoint inhibitor-related pneumonitis A Franken, P Van Mol, S Vanmassenhove, E Donders, R Schepers, ... Journal for immunotherapy of cancer 10 (9), 2022 | 31 | 2022 |
| The pulmonary vasculature in lethal COVID-19 and idiopathic pulmonary fibrosis at single-cell resolution LPMH De Rooij, LM Becker, LA Teuwen, B Boeckx, S Jansen, S Feys, ... Cardiovascular research 119 (2), 520-535, 2023 | 28 | 2023 |
| Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19 CP Martens, P Van Mol, J Wauters, E Wauters, T Gangnus, B Noppen, ... EBioMedicine 83, 2022 | 18 | 2022 |
| C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps BM Silva, GF Gomes, FP Veras, S Cambier, GVL Silva, AU Quadros, ... The Journal of Clinical Investigation 133 (12), 2023 | 16 | 2023 |
| An open resource for T cell phenotype changes in COVID-19 identifies IL-10-producing regulatory T cells as characteristic of severe cases J Neumann, T Prezzemolo, L Vanderbeke, CP Roca, M Gerbaux, ... MedRxiv, 2020.05. 31.20112979, 2020 | 15 | 2020 |
| High dimensional profiling identifies specific immune types along the recovery trajectories of critically ill COVID19 patients PA Penttilä, S Van Gassen, D Panovska, L Vanderbeke, Y Van Herck, ... Cellular and Molecular Life Sciences 78, 3987-4002, 2021 | 13 | 2021 |
| CONTAGIOUS collaborators, J. Neyts, J. Wauters, J. Qian, D. Lambrechts, Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of … E Wauters, P Van Mol, AD Garg, S Jansen, Y Van Herck, L Vanderbeke, ... Cell Res 31, 272-290, 2021 | 12 | 2021 |
| Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021; 12 (1): 4117 L Vanderbeke, P Van Mol, Y Van Herck, F De Smet, S Humblet-Baron, ... S41467-021-24360-W.[Europe PMC free article][Abstract][CrossRef][Academic Search], 0 | 9 | |
| Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective … S Feys, S Vanmassenhove, S Kraisin, K Yu, C Jacobs, B Boeckx, ... The Lancet Microbe 5 (3), e247-e260, 2024 | 8 | 2024 |
| Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients S Cambier, F Beretta, N Pörtner, M Metzemaekers, AC de Carvalho, ... Cellular and Molecular Life Sciences 80 (8), 234, 2023 | 6 | 2023 |
| CONTAGIOUS collaborators. 2021. Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages E Wauters, P Van Mol, AD Garg, S Jansen, Y Van Herck, L Vanderbeke, ... Cell Res 31, 272-290, 0 | 6 | |
| Lung aeration in COVID-19 pneumonia by ultrasonography and computed tomography A Kalkanis, C Schepers, Z Louvaris, L Godinas, E Wauters, D Testelmans, ... Journal of Clinical Medicine 11 (10), 2718, 2022 | 5 | 2022 |
